Epilepsy Trial, Recruiting (NCT06504511)

Epilepsy Trial, Recruiting NCT06504511 Sponsor: NHS Greater Glasgow and Clyde Condition: Epilepsy

Printed from Voxsanity (voxsanity.com.au) — NCT06504511 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Epilepsy

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

"Who might be able to join this trial:

You (or your legal representative) must be willing and able to give consent to take part in the study.
You and your parent or caregiver must be willing and able to follow all the requirements of the study, including attending virtual (online) appointments.
You must have a confirmed or likely harmful change (variant) in a gene called SCN1A, shown through genetic testing.

Who may not be able to join:

You may not be able to join if you have another significant health condition that, in the doctor's opinion, could put you at risk by taking part, or could make it difficult for you to participate in the study.

Important: Always verify eligibility with the trial site directly before applying."

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 23 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Andreas Brunklaus, MD PhD, NHS Greater Glasgow & Clyde

Phone: 0141 451 5888

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06504511

Sponsor: NHS Greater Glasgow and Clyde

Phase: Not Applicable

Status: Recruiting

Condition: Epilepsy

Trial contact: 0141 451 5888

More information: https://clinicaltrials.gov/study/NCT06504511

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

"Who might be able to join this trial:

You (or your legal representative) must be willing and able to give consent to take part in the study.
You and your parent or caregiver must be willing and able to follow all the requirements of the study, including attending virtual (online) appointments.
You must have a confirmed or likely harmful change (variant) in a gene called SCN1A, shown through genetic testing.

Who may not be able to join:

You may not be able to join if you have another significant health condition that, in the doctor's opinion, could put you at risk by taking part, or could make it difficult for you to participate in the study.

Important: Always verify eligibility with the trial site directly before applying."

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 23 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

NHS Greater Glasgow and Clyde

Registry

ClinicalTrials.gov

Start date

20 November 2023

Est. completion

1 June 2026

Where this trial is recruiting

🇬🇧 United Kingdom

Primary endpoints

Countable convulsive seizures per month; Bayley Scales of Infant and Toddler Development 4th UK Edition (Bayley-4); Wechsler Preschool and Primary Scale of Development 4th UK Edition (WPPSI-IV); Wechsler Intelligence Scale for Children 5th UK Edition (WISC-V); Wechsler Adult Intelligence Scale 4th UK Edition (WAIS-IV); Vineland Adaptive Behaviour Scales - Third Edition

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov